Banner: investors

News Releases

Recent Norovirus Outbreaks in National Media Headlines - Highly Effective PURE® Hard Surface Disinfectant Kills Norovirus in 60 Seconds

January 27, 2017

SAN DIEGO (Jan. 27, 2017) PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, has published a Norovirus Technical Bulletin highlighting the unique and powerful effectiveness of EPA-registered PURE® Hard Surface disinfectant and food contact surface sanitizer and its use to prevent and kill the Norovirus in 60 seconds. The bulletin was  published in response to recent Norovirus media coverage (including the Wall St. Journal, ABC News, and The Today Show) about the highly contagious and rapidly spreading virus.

 Preventing Transmission of Norovirus

Norovirus is the leading cause of gastroenteritis outbreaks in the U.S. This virus is extremely contagious and can infect anyone by transmission of contaminated food, water, surfaces or another person. Infected food workers cause about 70% of reported Norovirus outbreaks by adulterating ready-to-eat foods.

 PURE Hard Surface is being used for Norovirus protection by a number of national  restaurant  chains, including its recent adoption by Chipotle Mexican Grill, in addition to a growing number of food manufacturers and processors.

 According to the CDC, taking all necessary precautions to prevent transmission is crucial. Key to preventing the transmission of rapidly spreading Norovirus (especially in close quarters such as restaurants, hospitals, nursing homes, schools and cruise ships) is the frequent use of an effective EPA registered antimicrobial to clean and disinfect surfaces - especially on high-touch surfaces.

 PURE Hard Surface: The Right Choice

  • EPA-registered PURE Hard Surface disinfectant and food contact surface sanitizer is effective in eliminating Norovirus from surfaces in addition to many other viruses, bacteria and fungi.
  • PURE Hard Surface eliminates Norovirus in 60-seconds and completely kills other resistant pathogens like MRSA and VRE and also effectively eliminates dangerous fungi and viruses including Hep B, Hep C, HIV, Influenza A, Avian Influenza and H1N1 and is compliant with OSHA Bloodborne Pathogen standards.
  • PURE Hard Surface also provides 24-hour residual protection.
  • PURE Hard Surface is registered for use on food contact surfaces without a rinse and is gentle enough to be used in childcare areas.

 

Hank R. Lambert, Chief Executive Officer, recently said that he looks forward to 2017 being a breakout year for PURE. The Company is uniquely positioned to offer solutions to the industry’s most pressing challenges of implementing preventive controls and environmental monitoring; reducing the risks of food contamination and foodborne illness outbreaks, and the attendant financial and legal consequences; and protecting companies’ most valuable assets, their brands.

 

About PURE Bioscience, Inc.

PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and it mitigates bacterial resistance. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

 

Forward-looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from any forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including the Company’s ability to convert successful evaluations and tests into customer orders and customers continuing to place product orders as expected and to expand their use of the Company’s products; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw meat processing and to expand its use in OLR poultry processing; competitive factors; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2016, its Form 10-Q for the first quarter ended October 31, 2016. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

 

Contacts:

 

Hank Lambert, CEO

Terri MacInnis, VP of IR

Tom Hemingway

PURE Bioscience, Inc.

Bibicoff + MacInnis, Inc.

Redwood Investment Group

619-596-8600 ext.103

818-379-8500

714-978-4425

hlambert@purebio.com             

terri@bibimac.com

tomh@redwoodfin.com